Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Nov 9, 2017 · 10-Q · 40 days after period end · 0001493152-17-012713
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$1.92M | -$1.10M | -$838.89K | -$783.30K |
| EPS Diluted | -$0.36 | -$0.36 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end
